ArticleScientific reports2025
Evaluation of the diagnostic concordance of FDA-approved PD-L1 assays in clear cell renal cell carcinoma.
Yoko Koh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it